CVI-VZV-001

· CHA Vaccine Institute Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CVI-VZV-001, covering 2024-11-19 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of CVI-VZV-001 in Adults Aged 50 Years and Above [Phase 2]